Erich Spangenberg, one of the principal architects of a campaign challenging the validity of more than 30 pharmaceutical patents at the U.S. Patent and Trademark Office, has suggested that PTO Director Michelle Lee may have interfered with challenges brought by his campaign.
February 29, 2016 at 07:23 PM
1 minute read
The original version of this story was published on Corporate Counsel
Update: This article was updated to include a statement from the U.S. Patent and Trademark Office.
Erich Spangenberg, one of the principal architects of a campaign challenging the validity of more than 30 pharmaceutical patents at the U.S. Patent and Trademark Office, suggested on Monday that PTO Director Michelle Lee may have interfered with challenges brought by his campaign.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
